Xiidra 5% eye drops 5S
Ended Awarded Last action
- Contract number
- SPE2DR26FXPM2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,953
Award facts
- Contract value 100% obligated
- $12,953.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,953.03 to AmerisourceBergen Drug Corp for Xiidra 5% eye drops on December 8, 2025, with completion scheduled for December 9, 2025. This firm fixed-price delivery order was awarded competitively without a set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999,999,999 global pharmaceutical support vehicle running through December 2026 that authorizes the distributor to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's demonstrated capability in meeting federal procurement requirements across multiple therapeutic domains, combined with its status as a prime pharmaceutical vendor for the Defense Logistics Agency's medical supply chain, positions it to fulfill this specialized pharmaceutical delivery. Xiidra, an ophthalmic solution used to treat dry eye disease, represents the type of specialized medical commodity that supports the broader healthcare mission of the Defense Health Agency and other federal military medical systems served through the DLA's pharmaceutical contracting programs.
Quick answers
Who was awarded contract SPE2DR26FXPM2?
SPE2DR26FXPM2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 8, 2025.
How much is contract SPE2DR26FXPM2 worth?
The government has obligated $12,953 on SPE2DR26FXPM2.
Is contract SPE2DR26FXPM2 an order under another contract?
Yes. SPE2DR26FXPM2 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXPM2 competed?
The extent of competition for SPE2DR26FXPM2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award